Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

(2016) Jing He et al.   NATURE MEDICINE

Engagement of SLAMF3 enhances CD4+T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus

(2016) Denis Comte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

(2015) Caroline von Spee-Mayer et al.   ANNALS OF THE RHEUMATIC DISEASES

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE

(2015) Jens Y Humrich et al.   ANNALS OF THE RHEUMATIC DISEASES

T cells as a therapeutic target in SLE

(2015) D Comte et al.   LUPUS

Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy

(2013) Wei Liao et al.   IMMUNITY

SPICE: Exploration and analysis of post-cytometric complex multivariate datasets

(2011) Mario Roederer et al.   CYTOMETRY PART A

Inflammatory Cytokines in Systemic Lupus Erythematosus

(2011) Kim Ohl et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus

(2011) Sokratis A. Apostolidis et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Systemic Lupus Erythematosus

(2011) George C. Tsokos   NEW ENGLAND JOURNAL OF MEDICINE

IL-2 Family of Cytokines in T Regulatory Cell Development and Homeostasis

(2008) Thomas R. Malek et al.   JOURNAL OF CLINICAL IMMUNOLOGY